Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Neovascular Age-Related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00444249
What this trial is testing

Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 136
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Not applicableStudy completedNCT01245387
What this trial is testing

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related Macular DegenerationNeovascular Macular Degeneration
Pfizer 1,001
Not applicableEnded earlyNCT01337414
What this trial is testing

Tools to Optimize Patient Presentation After Onset of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular Degeneration
Johns Hopkins University 324
Not applicableEnded earlyNCT04764656
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 81
Not applicableStudy completedNCT00460408
What this trial is testing

Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Pfizer 501
Not applicableUnknownNCT03893474
What this trial is testing

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners

Who this might be right for
AMD
Moorfields Eye Hospital NHS Foundation Trust 742
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Not applicableEnded earlyNCT03275753
What this trial is testing

Visual Function Tests in Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
ORA, Inc. 200
Not applicableUnknownNCT04469140
What this trial is testing

Non Exudative AMD Imaged With SS-OCT- Extension

Who this might be right for
Dry Macular Degeneration
Boston Image Reading Center 450
Not applicableUnknownNCT00380172
What this trial is testing

Long-Term Efficacy in AMD of Rheopheresis in North America

Who this might be right for
Macular Degeneration
OccuLogix 120
Not applicableStudy completedNCT01712841
What this trial is testing

Non-exudative Age-related Macular Degeneration

Who this might be right for
Non-exudative Age-related Macular Degeneration
Oregon Health and Science University 30
Not applicableStudy completedNCT02218177
What this trial is testing

Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 30
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Early research (Phase 1)WithdrawnNCT02450981
What this trial is testing

Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Biocad
Early research (Phase 1)Study completedNCT01013376
What this trial is testing

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Who this might be right for
Age-Related Macular Degeneration
MacuCLEAR, Inc. 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more
Perceive Biotherapeutics, Inc. 60
Next Page